Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
NM
Nordic Medical Solutions Scandinavia ApS
aktivCVR 40641246AnpartsselskabAxeltorv 2F, 5, 1609 København VEngroshandel med medicinalvarer og sygeplejeartikler
- Latest accounts
- 2026
- Statement scope
- Standalone
- Verified
- 05 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2026
Revenue
Not available from the published filing—
Not available from the published filing
Operating profit
DKK 3.7m
Latest period
Source details
Source: dk-regnskabsdata-live-40641246-1793897552436
Document: dk-regnskabsdata-40641246-AaGrFU5vaNDWUdobKN-0-1
XBRL: c:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: c40
Unit: u1
Net result
DKK 2.8m
Latest period
Source details
Source: dk-regnskabsdata-live-40641246-1793897552436
Document: dk-regnskabsdata-40641246-AaGrFU5vaNDWUdobKN-0-1
XBRL: c:ProfitLoss
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: c40
Unit: u1
Equity
DKK 3.8m
Equity ratio: 28.7%
Source details
Source: dk-regnskabsdata-live-40641246-1793897552436
Document: dk-regnskabsdata-40641246-AaGrFU5vaNDWUdobKN-0-1
XBRL: c:Equity
Period: 01 Jul 2025 - 30 Jun 2026
Technical details
Context: c178
Unit: u1
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2023 | — | DKK 650.9k |
| 2024 | — | DKK 509.1k |
| 2025 | — | DKK 467.3k |
| 2026 | — | DKK 2.8m |